Application | Comment | Organism |
---|---|---|
synthesis | usage of the recombinant PAM for insulin analogue amidation producing insulin glargine amide, an insulin derivative that shows a time/effect profile which is distinctly more flat and thus more advantageous than insulin glargine itself. The enzyme is used to modify glycine-extended A22(G)-B31(K)-B32(R) human insulin analogue (GKR). Hypoglycemic activity of amidated and non-amidated insulin is compared | Homo sapiens |
Cloned (Comment) | Organism |
---|---|
gene PAM, stable recombinant expression of PAM in CHO dhfr cells, construction of pCG/dhfr plasmid with added PAMLID gene incorporating the altered leader sequence | Homo sapiens |
Metals/Ions | Comment | Organism | Structure |
---|---|---|---|
Cu2+ | dependent on | Homo sapiens |
Natural Substrates | Organism | Comment (Nat. Sub.) | Natural Products | Comment (Nat. Pro.) | Rev. | Reac. |
---|---|---|---|---|---|---|
insulin + ascorbate + O2 | Homo sapiens | - |
? + dehydroascorbate + H2O | - |
? |
Organism | UniProt | Comment | Textmining |
---|---|---|---|
Homo sapiens | P19021 | - |
- |
Purification (Comment) | Organism |
---|---|
recombinant PAM from CHO dhfr cells by ammonium sulfate fractionation and anion exchange chromatography | Homo sapiens |
Substrates | Comment Substrates | Organism | Products | Comment (Products) | Rev. | Reac. |
---|---|---|---|---|---|---|
insulin + ascorbate + O2 | - |
Homo sapiens | ? + dehydroascorbate + H2O | - |
? | |
insulin glargine + ascorbate + O2 | - |
Homo sapiens | ? + dehydroascorbate + H2O | - |
? |
Synonyms | Comment | Organism |
---|---|---|
PAM | - |
Homo sapiens |
peptidylglycine alpha-amidating monooxygenase | - |
Homo sapiens |
Temperature Optimum [°C] | Temperature Optimum Maximum [°C] | Comment | Organism |
---|---|---|---|
37 | - |
assay at | Homo sapiens |
pH Optimum Minimum | pH Optimum Maximum | Comment | Organism |
---|---|---|---|
6 | - |
assay at | Homo sapiens |
Cofactor | Comment | Organism | Structure |
---|---|---|---|
ascorbate | - |
Homo sapiens |
General Information | Comment | Organism |
---|---|---|
physiological function | PAM is the only known enzyme responsible for the bioconversion of glycine C-terminal prohormones into des-glycine alpha-amidated products and glyoxylate. PAM is a bifunctional, type-II copper monooxygenase that consists of two independent catalytic domains, PHM and PAL. The PAM reaction is a two-step process. Initially, PHM removes the pro-S hydrogen to allow hydroxylation of the alpha-glycyl carbon, resulting in an alpha-hydroxylated intermediate. PHM is a molecular oxygen, Cu(II) and ascorbate (reductant) dependent enzyme. The second catalytic domain, PAL, dealkylates the alpha-hydroxylated intermediate, yielding the alpha-amidated product and glyoxylate. PAM is responsible for the posttranslational modification of many important neuropeptides, including oxytocin, vasopressin, ACTH, alphaMSH, VIP, substance P, neuropeptide Y, cholecystokinin, gastrin, and a large number of other molecules. Hypoglycemic effect of the alpha-amidated analogue of recombinant human insulin | Homo sapiens |